GFS Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
GFS Advisors's LLY Position: Q2 2026 in Review
GFS Advisors sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 420 shares — an estimated $386K sold.
GFS Advisors first reported a position in LLY in Q1 2018 and held it in 14 quarters. The position peaked at $909K in Q3 2023. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- GFS Advisors reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- GFS Advisors sold 420 Eli Lilly shares in Q2 2026, an estimated $386K.
- GFS Advisors first reported a position in Eli Lilly in Q1 2018 and held it in 14 quarters.
- GFS Advisors's Eli Lilly position peaked at $909K in Q3 2023.
- 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on GFS Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.